Clinical insights from observations on ADAMTS13 deficiency in liver cirrhosis.
George
James N
JN
College of Public Health and Medicine, The University of Oklahoma Health Sciences Center, Hematology-Oncology Section, Oklahoma City, OK 73126-0901, USA. james-george@ouhsc.edu
D051722:ADAM Proteins / Q000097:blood* / Q000172:deficiency / Q000276:immunology; D000071120:ADAMTS13 Protein; D001323:Autoantibodies / Q000097:blood; D016207:Cytokines / Q000097:blood; D015536:Down-Regulation; D019694:Hepatitis B, Chronic / Q000150:complications / Q000201:enzymology; D019698:Hepatitis C, Chronic / Q000150:complications / Q000201:enzymology; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications / Q000201:enzymology* / Q000473:pathology / Q000821:virology; D010976:Platelet Count; D011697:Purpura, Thrombotic Thrombocytopenic / Q000201:enzymology / Q000209:etiology* / Q000473:pathology; D012720:Severity of Illness Index; D014841:von Willebrand Factor / Q000378:metabolism*
D001323:Autoantibodies; D016207:Cytokines; D014841:von Willebrand Factor; D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human